Monroe B S, Warner D
University Medical Center, Tucson, Ariz., USA.
Crit Care Nurse. 1998 Dec;18(6):73-80.
Intrapleural administration of fibrinolytic agents can be used to degrade the fibrin present in complicated pleural effusions, thus decreasing viscosity of the fluid and enhancing evacuation of the pleural space via chest tube drainage. Patients who may otherwise need surgical intervention could benefit from this treatment. As more knowledge is gained through clinical experience and research studies, patients' outcomes may show major improvement.
胸膜腔内注射纤溶药物可用于降解复杂胸腔积液中存在的纤维蛋白，从而降低液体粘度，并通过胸腔闭式引流增强胸腔内液体的排出。否则可能需要手术干预的患者可能会从这种治疗中受益。随着通过临床经验和研究获得更多知识，患者的治疗效果可能会有显著改善。
